Stay updated with breaking news from Abt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Geneva Partners LLC lessened its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 38.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,135 shares of the healthcare product maker’s stock after selling 2,552 shares during the period. […]
ZWJ Investment Counsel Inc. cut its position in Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 47,231 shares of the healthcare product maker’s stock after selling 147 shares during the quarter. ZWJ Investment […]
Arcblock (ABT) traded up 4% against the US dollar during the 24-hour period ending at 0:00 AM Eastern on April 19th. One Arcblock token can now be purchased for approximately $2.24 or 0.00003485 BTC on major exchanges. Arcblock has a total market cap of $220.47 million and approximately $1.72 million worth of Arcblock was traded […]
Carmel Capital Partners LLC reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 18.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,032 shares of the healthcare product maker’s stock after selling 670 shares during the quarter. Carmel Capital Partners LLC’s […]
Nicholas Hoffman & Company LLC. grew its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.8% in the fourth quarter, HoldingsChannel reports. The firm owned 13,787 shares of the healthcare product maker’s stock after buying an additional 377 shares during the quarter. Nicholas Hoffman & Company LLC.’s holdings in Abbott Laboratories were […]